IGF1R and rheumatoid arthritis: The C-type lectins upregulated in IGF1RloCD14+ cells of RA patients and in APC after IGF1R inhibition in mice and their emerging immune regulatory function (47, 50, 51) are the candidate mediators of such an interaction.